Agenda

Registration & Networking

Breakthroughs in Blood Diseases

After two decades of ups and downs, gene therapy’s first successes have come against rare diseases with tiny populations. Will the deadly blood diseases sickle cell and beta-thalassemia be next?

Sandy Macrae – President & CEO, Sangamo Therapeutics
David Martin – Deputy Director, Children’s Hospital Oakland Research Institute (CHORI); Senior Scientist & Chair, CHORI Center for Genetics
Alex Lash (moderator) – National Biotech Editor, Xconomy

Your Genes Have Bad News. Now What?

Genetic testing is outpacing society’s ability to treat disease. Just because you receive a bad diagnosis, or a red flag for high risk, doesn’t mean you’ll have a treatment. Counseling, ethics, and privacy are all growing concerns in this new medical era.

Lisa Alderson, Co-founder & CEO, Genome Medical
Aleksandar Rajkovic – Chief Genomics Officer, UCSF
Bonnie Anderson (moderator) – CEO, Veracyte

A Deeper Dive for Drugs

Genomics is information, but beyond the buzzwords—“AI” is the latest one being tossed around—how fast can deeper data bring us much-needed treatments?

Jason Coloma – CEO, Maze Therapeutics
Daphne Koller – CEO & Founder, insitro

Networking Reception